Abstract

ABSTRACTImmune response is a highly coordinated cascade involving all the subsets of peripheral blood mononuclear cells (PBMCs). In this study, RNA sequencing (RNA-Seq) analysis of PBMC subsets was done to delineate the systems biology behind immune protection of the vaccine in sheep and goats. The PBMC subsets studied were CD4+, CD8+, CD14+, CD21+, and CD335+ cells from day 0 and day 5 of sheep and goats vaccinated with Sungri/96 peste des petits ruminants virus. Assessment of the immune response processes enriched by the differentially expressed genes (DEGs) in all the subsets suggested a strong dysregulation toward the development of early inflammatory microenvironment, which is very much required for differentiation of monocytes to macrophages, and activation as well as the migration of dendritic cells into the draining lymph nodes. The protein-protein interaction networks among the antiviral molecules (IFIT3, ISG15, MX1, MX2, RSAD2, ISG20, IFIT5, and IFIT1) and common DEGs across PBMC subsets in both species identified ISG15 to be a ubiquitous hub that helps in orchestrating antiviral host response against peste des petits ruminants virus (PPRV). IRF7 was found to be the key master regulator activated in most of the subsets in sheep and goats. Most of the pathways were found to be inactivated in B lymphocytes of both the species, indicating that 5 days postvaccination (dpv) is too early a time point for the B lymphocytes to react. The cell-mediated immune response and humoral immune response pathways were found more enriched in goats than in sheep. Although animals from both species survived the challenge, a contrast in pathway activation was observed in CD335+ cells.IMPORTANCE Peste des petits ruminants (PPR) by PPR virus (PPRV) is an World Organisation for Animal Health (OIE)-listed acute, contagious transboundary viral disease of small ruminants. The attenuated Sungri/96 PPRV vaccine used all over India against this PPR provides long-lasting robust innate and adaptive immune response. The early antiviral response was found mediated through type I interferon-independent interferon-stimulated gene (ISG) expression. However, systems biology behind this immune response is unknown. In this study, in vivo transcriptome profiling of PBMC subsets (CD4+, CD8+, CD14+, CD21+, and CD335+) in vaccinated goats and sheep (at 5 days postvaccination) was done to understand this systems biology. Though there are a few differences in the systems biology across cells (specially the NK cells) between sheep and goats, the coordinated response that is inclusive of all the cell subsets was found to be toward the induction of a strong innate immune response, which is needed for an appropriate adaptive immune response.

Highlights

  • Immune response is a highly coordinated cascade involving all the subsets of peripheral blood mononuclear cells (PBMCs)

  • The number of unique differentially expressed genes (DEGs) was highest in the CD211 cells of goats and CD3351 cells of sheep (Fig. 1C and D)

  • The absence of expression of type I interferons in our study suggested IFN-independent interferon-stimulated gene (ISG) stimulation as reported previously for Peste des petits ruminants (PPR) [7]

Read more

Summary

Introduction

Immune response is a highly coordinated cascade involving all the subsets of peripheral blood mononuclear cells (PBMCs). RNA sequencing (RNA-Seq) analysis of PBMC subsets was done to delineate the systems biology behind immune protection of the vaccine in sheep and goats. The PBMC subsets studied were CD41, CD81, CD141, CD211, and CD3351 cells from day 0 and day 5 of sheep and goats vaccinated with Sungri/96 peste des petits ruminants virus. In vivo transcriptome profiling of PBMC subsets (CD41, CD81, CD141, CD211, and CD3351) in vaccinated goats and sheep (at 5 days postvaccination) was done to understand this systems biology. A predicted immune signaling pathway of PPRV Sungri/96 vaccineinduced immune response with the predominant role of interferon regulatory factors (IRFs), tripartite motif family (TRIMs), and interferon-stimulated genes (ISGs) in creation of a robust antiviral state in vitro in PBMCs has been proposed [7]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call